                                                                    EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Advanced Biotherapy, Inc. (the
"Company") on Form 10-QSB for the quarter ended June 30, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the "Periodic Report"),
I, William M. Finkelstein, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

            1.    the Periodic Report fully complies with the requirements of
                  Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
                  and

            2.    the information contained in the Periodic Report fairly
                  presents, in all material respects, the financial condition
                  and results of operations of the Company.


Dated: August 20, 2006                       /s/William M. Finkelstein
                                             -----------------------------------
                                             Chief Financial Officer
